About Us
Medical Blog
  • J&J Acquires Abiomed for $16.6 Billion

    Johnson & Johnson ("J&J") announced on November 1, 2022, that it will acquire Abiomed for an upfront payment of $380.00 per share in cash, which equates to about $16.6 billion.  The acquisition is expected to be completed in the first quarter of 2023.  According to reports, after the acquisition, Abiomed "will operate as a standalone business within J&J within Johnson & Johnson M ...
  • Report: Medical Device Market Expected to Grow Over Next Seven Years

    An article from October 2022 states that the global medical device market is projected to jump by seven billion dollars in 2022 and leap to $223 billion over the next seven years, to reach a valuation of around $719 billion by 2029. A report by consulting firm Fortune Business Insights anticipates a 5.5% compound annual growth rate (CAGR) over this period. The report identifies several factors ...
  • FDA Grants Breakthrough Device Designation for EndoStim’s GERD Treatment

    EndoStim announced on October 25th that the FDA granted a breakthrough device designation for the company’s implantable neurostimulation treatment for drug refractory gastroesophageal reflux disease (GERD). EndoStim states that its EndoStim System is the first-in-class implantable neurostimulation treatment for GERD. While traditional surgery for the treatment of GERD requires wrapping the sto ...
Conferences